ArticleCureus2025
Prevalence of Hemoglobinopathies Among the Kurdish Population in Zakho City, Kurdistan Region, Iraq.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Thalassemia in Iraq: Time to Reform Policy.Rwanda journal of medicine and health sciences · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHemoglobinopathies are the most common inherited disorders in the Mediterranean region, including Iraq, with different frequencies and molecular features. They represent an important health problem in Iraq. Several studies have addressed the prevalence of hemoglobinopathy in Iraq, but no specific research has addressed its prevalence in Zakho city, Kurdistan Region, Iraq. Thus, this study was conducted to address this issue. MATERIALS AND
methodsA prospective cross-sectional study was conducted in a premarital screening center at Zakho Emergency Teaching Hospital, involving 11,910 Kurdish persons attending premarital screening investigations. Blood samples were collected from all participants for complete blood counts and sickling tests. A cut-off value of hemoglobin (Hb) concentrations (<13.0 gm/dl in males, <12.0 gm/dl in females), mean cell volume (MCV) <80 fl and/or mean cell hemoglobin (MCH) <27 pg, and the results of the sickling test were used to categorize the participants into three groups: group I, normal (normal Hb, MCV, and MCH, and negative sickling test); group II, individuals with MCV < 80 fl and/or MCH < 27 pg, with or without anemia, and negative sickling test; group III, sickle positive (individuals with a positive sickling test, with or without anemia, regardless of MCV and/or MCH values). Groups II and III underwent further evaluations by morphology, reticulocyte count, hemoglobin-H preparation, iron studies, and cation exchange high-performance liquid chromatography (HPLC). β-thalassemia trait was diagnosed by hypochromic microcytic red cell indices and increased hemoglobin A2 (HbA2) (>3.5%). The sickle cell trait was diagnosed by the presence of a band at the S region at HPLC with a positive sickling test. Iron deficiency anemia (IDA) was diagnosed by hypochromic microcytic anemia and reduced transferrin saturation (<15%) and/or ferritin (<15 mg/L). Descriptive statistical analyses were conducted to define significant differences between the study's findings.
resultsA total of 963 (8.09%) of the studied participants were in group II. Further investigations on these 963 cases confirmed a diagnosis of IDA in 610 (5.12%). β-thalassemia trait was detected in 308 cases, with an overall prevalence of 2.59%. δβ-thalassemia trait was detected in nine (0.076%) of the studied participants. A professional diagnosis of α-thalassemia was given to 36 (0.30%) of those with hypochromic microcytic red cell indices, normal iron studies, and HPLC results. A positive sickling test was seen in 48 participants and confirmed by HPLC as a sickle cell trait with a prevalence of 0.4%. The consanguinity rate among couples was 28.8%. Neither case of HbC or HbD trait, nor combined hemoglobinopathy, was detected in the current study. Furthermore, no differences were found between the prevalence of both β thalassemia and sickle cell trait with either sex and/or religion, with a p-value of 0.07, 0.07, 0.532, and 0.78, respectively.
conclusionThe prevalence of hemoglobinopathy in Zakho city is lower than in other regions of Iraq but still constitutes a significant burden on health services and financial resources. Careful interpretations of red cell indices, together with intensified premarital screening and counseling programs, coupled with an urgent need to increase awareness about the effects of consanguinity marriages on the prevalence of autosomal recessive disorders, can further reduce the incidence of hemoglobinopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.